Acute Kidney Injury Treatment MarketThe global Acute Kidney Injury (AKI) Treatment Market is poised for significant growth, ...

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

Bone fracture may be among the adverse outcomes of acute kidney injury (AKI), investigators suggest. In a retrospective study of 123,426 Australian adults, 14,549 (12%) experienced an AKI episode and ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces ...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute ...

Prerenal azotemia is a common occurrence in hospitalized patients and is generally easier to define in clinical practice than in clinical research. Monitoring the duration of acute kidney injury ...

which could have a lasting impact on getting patients diagnosed earlier. AIN is a common cause of acute kidney injury, or AKI, marked by swelling and inflammation of certain kidney tissues ...

Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.